Understanding the differences in small cell lung cancer and how they affect treatment outcomes
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
This study is looking at the different ways small cell lung cancer can behave in order to find out how these differences affect treatment and chances of coming back, so that doctors can create better, personalized treatment plans just for you.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11092311 on NIH RePORTER |
What this research studies
This research investigates the molecular and immunological differences in small cell lung cancer (SCLC) to better understand how these variations impact treatment responses and the likelihood of relapse. By identifying distinct subtypes of SCLC based on specific genetic markers and immune characteristics, the study aims to develop more effective, personalized treatment strategies. Patients will be evaluated for their tumor's unique features, which may help in selecting the most appropriate therapies and improving overall outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with small cell lung cancer who are seeking advanced treatment options.
Not a fit: Patients with non-small cell lung cancer or those who are not diagnosed with any form of lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more tailored and effective treatment options for patients with small cell lung cancer.
How similar studies have performed: Previous research has shown promise in understanding the molecular diversity of cancers, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Byers, Lauren Averett — University of Tx Md Anderson Can Ctr
- Study coordinator: Byers, Lauren Averett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.